Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2725 of 5804
-
New drug ML-004 moves to safety testing in autism patients
Disease control OngoingML-004-003 is a multi-center, open-label extension study that will enroll approximately 120 adolescent and adult subjects with ASD that have completed study ML-004-002. The primary objective of the study will be to evaluate the safety of ML-004 in subjects with ASD.
Phase: PHASE2 • Sponsor: MapLight Therapeutics • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Lab-Grown vaginas: first human trial launches
Disease control Recruiting nowIn this Phase 1, single site, clinical trial, Vulvar/vaginal Smooth muscle cells (SMC) and Epithelial Cells (EPC) are isolated from autologous patient's biopsy
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Exercise booster? CoQ10 may help kidney patients build muscle
Disease control Recruiting nowFrailty and sarcopenia are modifiable risk factors for morbidity and mortality in patients with ESRD. Exercise is the recommended intervention to prevent frailty and sarcopenia, however, many clinical trials have shown limited clinical improvement in muscle mass and physical func…
Phase: PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
3D-Printed jaw models help surgeons rebuild faces more accurately
Disease control CompletedThree-dimensional (3D) printing is increasingly used in surgery to help doctors plan and perform complex operations with greater accuracy. In this study, the investigators used 3D-printed jaw models to assist in rebuilding the lower jaw (mandible) after tumor removal, using bone …
Phase: NA • Sponsor: Indonesia University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study aims to stop vaginal dryness before it starts in breast cancer patients
Prevention Recruiting nowResearchers are doing this study to look at whether sexual health counselling and using non-hormonal moisturizer at the start of ovarian suppression may be able to prevent or reduce side effects such as vaginal dryness and sexual dysfunction. Researchers will compare how effectiv…
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 12:02 UTC
-
New combo tackles pancreatic cancer resistance – but study halted early
Disease control TerminatedThis study is designed to investigate the means by which cancer resists treatment can be overcome by a combination of an established anticancer drug, trametinib, with hydroxychloroquine.
Phase: PHASE2 • Sponsor: Cancer Trials Ireland • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New eye implant aims to ease glaucoma pressure without daily drops
Disease control Recruiting nowTo evaluate the safety and feasibility of the Calibreye System in patients with open angle glaucoma.
Phase: NA • Sponsor: Myra Vision Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Can a pill regrow knee cartilage? new trial tests RHH646
Disease control CompletedThe purpose of this study was to evaluate the articular cartilage-regenerating capacity of RHH646 in the knee as well as to assess safety and tolerability in participants with knee osteoarthritis.
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can kitchen spices soothe gulf war illness? new trial seeks answers
Symptom relief CompletedThis project's objective is to identify effective treatments for Gulf War Illness (GWI). The project tests three potential treatments: curcumin, stinging nettle, and resveratrol. The project uses a decentralized clinical trial (DCT) design in which individuals can participate fro…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Symptom relief
Last updated Jul 01, 2026 00:00 UTC
-
New hope for chronic pain sufferers: simple online programs tested before specialist care
Symptom relief CompletedThe development of alternative methods to address simple clinical needs and easy interventions of self-application are desired in the pre-habilitation period (waiting list). To our knowledge that are very few studies regarding interventions for patients in waiting list for specia…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Lung cancer combo trial halted early – what we know
Disease control TerminatedSLC-391 is a novel, potent and specific small molecule inhibitor of receptor tyrosine kinase AXL with desirable potency and pharmaceutical properties. The study is being done to evaluate the safety and pharmacokinetic (PK) profile of SLC-391 in combination with pembrolizumab in …
Phase: PHASE1, PHASE2 • Sponsor: SignalChem Lifesciences Corporation • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
App aims to boost resilience in young adults with adverse childhood experiences
Symptom relief CompletedThe FACE self-help app is an online intervention for young adults with Adverse Childhood Experiences (ACEs). It was developed based on well-established cognitive-behavioural therapy principles. The self-help app contains two components, one targeting emotion regulation (ER), the …
Phase: NA • Sponsor: Jeannette Brodbeck • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
New Light-Based monitor could spot brain trouble in newborns seconds after birth
Knowledge-focused Recruiting nowThe transition from fetus to newborn is a complex physiological process. Monitoring this process to detect potential disruptions is critical but remains a challenge. Initial evaluation of neonates is usually based on visual inspection, palpation and/or auscultation, and response …
Sponsor: Medical University of Graz • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Can a smartphone app ease the burden of Alzheimer's caregiving?
Symptom relief Recruiting nowThis study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by car…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
VR workouts boost fitness in cystic fibrosis kids
Symptom relief CompletedThe goal of this clinical trial is to investigate the effects of a-12-week virtual reality exercise program, applied as tele-exercise, on the exercise capacity of children with cystic fibrosis, whose physical activity level is further restricted during the pandemic. The main ques…
Phase: NA • Sponsor: Koç University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New drug duo takes on Hard-to-Treat cancers
Disease control Recruiting nowThis study will evaluate the safety and efficacy of DS-1103a combination therapy in participants with advanced solid tumors.
Phase: PHASE1 • Sponsor: Daiichi Sankyo • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Personalized cell therapy shows promise for Hard-to-Treat cancers
Disease control TerminatedBackground: Tumor-infiltrating lymphocyte (TIL) therapy is a type of adoptive cellular therapy by harvesting infiltrated lymphocytes from tumors, culturing and amplifying them in vitro and then infusing back to patients. TIL therapy has shown strong efficacy for the treatment o…
Phase: PHASE1 • Sponsor: Hervor Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Experimental combo for head and neck cancer shows promise, but trial halted early
Disease control TerminatedOpen-label, Phase II, randomized, controlled study evaluating the efficacy and safety of danvatirsen in combination with pembrolizumab compared with pembrolizumab alone as first-line treatment of patients with recurrent/metastatic (R/M) HNSCC. Two-thirds of patients will be rando…
Phase: PHASE2 • Sponsor: Flamingo Therapeutics NV • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New online program eases Kids' cancer return to school
Symptom relief CompletedThe aim of this action research is to: Stage 1: Conduct an in-depth investigation into the adaptation challenges faced by children aged 8-17 who are being treated for cancer during their return to school, from both the children's and parents' perspectives; Stage 2: Develop a st…
Phase: NA • Sponsor: Gazi University • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Parkinson's patients try Brain-Boosting workouts from home
Symptom relief CompletedThe ability to respond to multiple stimuli is impaired in Parkinson's patients. Traditional rehabilitation approaches focus only on balance and gait training, but individuals with Parkinson's disease need to perform multiple tasks in daily life.
Phase: NA • Sponsor: Yeditepe University • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC